Arstall, Margaret A.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 150

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 118

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Bohula, E. A., Scirica, B. M., Inzucchi, S. E., McGuire, D. K., Keech, A. C., Smith, S. R., Kanevsky, E., Murphy, S. A., Leiter, L. A., Dwyer, J. P., et al. (2018) · The Lancet

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 94

Continuous positive airway pressure treatment, glycemia, and diabetes risk in obstructive sleep apnea and comorbid cardiovascular disease

Loffler, K. A., Heeley, E., Freed, R., Meng, R., Bittencourt, L. R., Gonzaga Carvalho, C. C., Chen, R., Hlavac, M., Liu, Z., Lorenzi-Filho, G., et al. (2020) · Diabetes Care

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 52

Protective influence of breastfeeding on cardiovascular risk factors in women with previous gestational diabetes mellitus and their children: a systematic review and meta-analysis

Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation

Breastfeeding Practices and InfluencesGestational Diabetes Research and Management

Cited by 29

Prevalence of metabolic syndrome in women after maternal complications of pregnancy: an observational cohort analysis

Aldridge, E., Pathirana, M., Wittwer, M., Sierp, S., Leemaqz, S. Y., Roberts, C. T., Dekker, G. A., & Arstall, M. A. (2022) · Frontiers in Cardiovascular Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsPregnancy and preeclampsia studies

Cited by 17

A South Australian registry of biphasic cardioversions of atrial arrhythmias: efficacy and predictors of success

Wittwer, M. R., Rajendran, S., Kealley, J., & Arstall, M. A. (2015) · Heart Lung and Circulation

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 16

Effectiveness of a nurse practitioner-led cardiovascular prevention clinic at reduction of metabolic syndrome following maternal complications of pregnancy: a preliminary analysis

Aldridge, E., Pathirana, M., Wittwer, M., Sierp, S., Leemaqz, S. Y., Roberts, C. T., Dekker, G. A., & Arstall, M. A. (2022) · Diabetology & Metabolic Syndrome

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 6